Allogene Therapeutics, Inc.
ALLO
$1.45
$0.053.57%
NASDAQ
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | -34.82% | -37.37% | -9.62% | -18.33% | -13.27% |
Total Receivables | 11.76% | 75.00% | 81.82% | -22.73% | -48.48% |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 3.35% | 58.31% | 16.12% | 9.49% | 6.27% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | -33.92% | -35.70% | -8.96% | -17.88% | -13.18% |
|
|||||
Total Current Assets | -33.92% | -35.70% | -8.96% | -17.88% | -13.18% |
Net Property, Plant & Equipment | -19.56% | -25.44% | -19.41% | -16.37% | -16.93% |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 97.62% | 136.84% | 128.86% | -7.37% | 0.24% |
Total Assets | -14.64% | -17.30% | -16.10% | -21.49% | -21.76% |
|
|||||
Total Accounts Payable | -8.53% | -11.27% | 26.46% | -60.65% | -57.54% |
Total Accrued Expenses | -1.97% | -20.07% | -54.73% | -52.91% | -26.06% |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 10.83% | 12.33% | 13.16% | 11.97% | 12.88% |
Total Finance Division Other Current Liabilities | -55.83% | -- | -- | -68.50% | -40.96% |
Total Other Current Liabilities | -55.83% | -- | -- | -68.50% | -40.96% |
Total Current Liabilities | -4.20% | -13.46% | -31.83% | -48.15% | -30.99% |
|
|||||
Total Current Liabilities | -4.20% | -13.46% | -31.83% | -48.15% | -30.99% |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -5.77% | -5.51% | -5.26% | -4.92% | -7.12% |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | 49.86% | 415.88% | 395.80% | 242.58% | -11.42% |
Total Liabilities | -3.12% | -2.98% | -10.95% | -19.16% | -15.57% |
|
|||||
Common Stock & APIC | 8.03% | 7.96% | 8.33% | 8.10% | 8.56% |
Retained Earnings | -16.49% | -19.40% | -19.89% | -21.92% | -26.50% |
Treasury Stock & Other | 90.68% | 106.51% | 79.75% | 84.38% | 90.38% |
Total Common Equity | -17.58% | -20.47% | -17.32% | -22.10% | -23.19% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | -17.58% | -20.47% | -17.32% | -22.10% | -23.19% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -17.58% | -20.47% | -17.32% | -22.10% | -23.19% |
|